NDA 090879 describes RIVASTIGMINE TARTRATE, which is a drug marketed by
Alembic Pharms Ltd,
Apotex Inc,
Aurobindo Pharma,
Cadila Pharms Ltd,
Chartwell Rx,
Dr Reddys Labs Inc,
Macleods Pharms Ltd,
Orbion Pharms,
Sun Pharm, and
Watson Labs, and is included in ten NDAs. It is available from
thirteen suppliers. Additional details are available on the
RIVASTIGMINE TARTRATE profile page.
The generic ingredient in RIVASTIGMINE TARTRATE is
rivastigmine tartrate. There are thirty-two
drug master file entries for this compound. Thirteen
suppliers are listed for this compound. Additional details are available on the
rivastigmine tartrate profile page.